BR112014018953A2 - - Google Patents
Info
- Publication number
- BR112014018953A2 BR112014018953A2 BR112014018953A BR112014018953A BR112014018953A2 BR 112014018953 A2 BR112014018953 A2 BR 112014018953A2 BR 112014018953 A BR112014018953 A BR 112014018953A BR 112014018953 A BR112014018953 A BR 112014018953A BR 112014018953 A2 BR112014018953 A2 BR 112014018953A2
- Authority
- BR
- Brazil
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210027090 | 2012-02-08 | ||
| CN201310014849.XA CN103242413B (zh) | 2012-02-08 | 2013-01-15 | Lupane三萜系衍生物及其药学用途 |
| PCT/CN2013/071100 WO2013117137A1 (en) | 2012-02-08 | 2013-01-30 | Lupane triterpenoid derivatives and pharmaceutical use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014018953A2 true BR112014018953A2 (pt) | 2017-06-20 |
| BR112014018953A8 BR112014018953A8 (pt) | 2017-07-11 |
Family
ID=48922317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014018953A BR112014018953A8 (pt) | 2012-02-08 | 2013-01-30 | Derivados de lupano triterpenoide e uso farmacêutico dos mesmos |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9428542B2 (pt) |
| EP (1) | EP2812343B1 (pt) |
| JP (1) | JP5872074B2 (pt) |
| KR (1) | KR20140126739A (pt) |
| CN (1) | CN103242413B (pt) |
| AU (1) | AU2013218441A1 (pt) |
| BR (1) | BR112014018953A8 (pt) |
| CA (1) | CA2860581A1 (pt) |
| EA (1) | EA201491479A1 (pt) |
| HK (1) | HK1202553A1 (pt) |
| WO (1) | WO2013117137A1 (pt) |
| ZA (1) | ZA201405819B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014105926A1 (en) | 2012-12-31 | 2014-07-03 | Hetero Research Foundation | Novel betulinic acid proline derivatives as hiv inhibitors |
| US20170129916A1 (en) | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
| EP3218387A1 (en) * | 2014-11-14 | 2017-09-20 | VIIV Healthcare UK (No.5) Limited | Oxolupene derivatives |
| WO2016077572A1 (en) * | 2014-11-14 | 2016-05-19 | Bristol-Myers Squibb Company | Extended betulinic acid analogs |
| EP3218388A1 (en) * | 2014-11-14 | 2017-09-20 | VIIV Healthcare UK (No.5) Limited | C17-aryl substituted betulinic acid analogs |
| MA40886B1 (fr) | 2015-02-09 | 2020-03-31 | Hetero Research Foundation | Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih |
| WO2016147099A2 (en) | 2015-03-16 | 2016-09-22 | Hetero Research Foundation | C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors |
| WO2018029602A1 (en) * | 2016-08-08 | 2018-02-15 | Hetero Labs Limited | C-3 novel triterpenone with c-28 heterocycle derivatives as hiv inhibitors |
| WO2018029604A1 (en) * | 2016-08-08 | 2018-02-15 | Hetero Labs Limited | C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors |
| WO2018029610A1 (en) * | 2016-08-09 | 2018-02-15 | Hetero Labs Limited | C-3 novel triterpenone with c-17 n-amide derivatives as hiv inhibitors |
| WO2018065930A1 (en) * | 2016-10-05 | 2018-04-12 | Hetero Labs Limited | C-3 triterpenone with c-17 reverse amide derivatives as hiv inhibitors |
| WO2018069857A1 (en) * | 2016-10-12 | 2018-04-19 | Hetero Labs Limited | C-3 novel triterpenone with c-17 reverse amide heterocycle derivatives as hiv inhibitors |
| WO2019150300A1 (en) | 2018-02-02 | 2019-08-08 | Glaxosmithkline Intellectual Property (No.2) Limited | Crystalline forms of 4-(((3ar,5ar,5br,7ar,9s,11ar,11br,13as)-3a-((r)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2h-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid |
| PL237998B1 (pl) | 2018-05-28 | 2021-06-28 | Narodowy Inst Lekow | Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie |
| CN114369134A (zh) * | 2020-10-15 | 2022-04-19 | 江西青峰药业有限公司 | 一种Lupane三萜系衍生物葡甲胺盐无定型物及其制备方法和应用 |
| CN115504947B (zh) * | 2022-08-23 | 2024-04-26 | 山东和源制药有限公司 | 一种呋喃酮酸的制备方法 |
| CN116041415B (zh) * | 2023-02-01 | 2023-08-18 | 吉林农业大学 | 一种裂环羽扇豆烷衍生物及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008127364A2 (en) * | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
| AR063546A1 (es) * | 2006-11-03 | 2009-01-28 | Panacos Pharmaceuticals Inc | DERIVADOS DE TRITERPENO, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIoN POR EL VIRUS VIH. |
| WO2009073818A1 (en) * | 2007-12-04 | 2009-06-11 | Myriad Genetics, Inc. | Compounds and therapeutic use thereof |
| JP2011508748A (ja) * | 2008-01-03 | 2011-03-17 | バイロケム ファーマ インコーポレイテッド | 新規のルパン誘導体 |
| CN101977924A (zh) * | 2008-01-03 | 2011-02-16 | Viro化学制药公司 | 新的c-21-酮基羽扇烷衍生物、其制备方法和应用 |
| JP2013519674A (ja) | 2010-02-11 | 2013-05-30 | グラクソスミスクライン エルエルシー | ベツリンの誘導体 |
| JO3387B1 (ar) * | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
-
2013
- 2013-01-15 CN CN201310014849.XA patent/CN103242413B/zh active Active
- 2013-01-30 AU AU2013218441A patent/AU2013218441A1/en not_active Abandoned
- 2013-01-30 CA CA2860581A patent/CA2860581A1/en not_active Abandoned
- 2013-01-30 US US14/374,832 patent/US9428542B2/en not_active Expired - Fee Related
- 2013-01-30 EP EP13746137.2A patent/EP2812343B1/en active Active
- 2013-01-30 JP JP2014555064A patent/JP5872074B2/ja not_active Expired - Fee Related
- 2013-01-30 KR KR1020147025188A patent/KR20140126739A/ko not_active Application Discontinuation
- 2013-01-30 EA EA201491479A patent/EA201491479A1/ru unknown
- 2013-01-30 WO PCT/CN2013/071100 patent/WO2013117137A1/en active Application Filing
- 2013-01-30 BR BR112014018953A patent/BR112014018953A8/pt not_active IP Right Cessation
-
2014
- 2014-08-07 ZA ZA2014/05819A patent/ZA201405819B/en unknown
-
2015
- 2015-03-25 HK HK15103034.5A patent/HK1202553A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US9428542B2 (en) | 2016-08-30 |
| HK1202553A1 (en) | 2015-10-02 |
| AU2013218441A1 (en) | 2014-07-24 |
| CA2860581A1 (en) | 2013-08-15 |
| JP2015505545A (ja) | 2015-02-23 |
| KR20140126739A (ko) | 2014-10-31 |
| WO2013117137A1 (en) | 2013-08-15 |
| CN103242413B (zh) | 2015-08-26 |
| EA201491479A1 (ru) | 2014-11-28 |
| EP2812343B1 (en) | 2019-03-13 |
| ZA201405819B (en) | 2015-12-23 |
| JP5872074B2 (ja) | 2016-03-01 |
| BR112014018953A8 (pt) | 2017-07-11 |
| CN103242413A (zh) | 2013-08-14 |
| EP2812343A1 (en) | 2014-12-17 |
| US20150011517A1 (en) | 2015-01-08 |
| EP2812343A4 (en) | 2015-12-02 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |